Top

Quality of Life Research

Gepubliceerd in:

24-02-2017

The longitudinal course of depression symptomatology following a palliative rehabilitation program

Auteurs: Andrea Feldstain, Sophie Lebel, Martin R. Chasen

Gepubliceerd in: Quality of Life Research | Uitgave 7/2017

Abstract

Purpose

Patients with advanced cancer have increased life expectancy but suffer from ongoing burden. Depressive symptomatology is their most common mental health concern. The Ottawa Palliative Rehabilitation Program (PRP) offers rehabilitation for this population. It offers 8 weeks of individualized interdisciplinary rehabilitation, post cancer treatment. Interventions include medical (physician and nurse), physiotherapy, occupational therapy, dietary, and social work using a general self-efficacy framework. Pilot data suggest benefits in a range of domains, including ratings of feeling “depressed.” We examined whether reduced symptomatology was maintained 3 months after PRP completion.

Methods

Participants with advanced heterogeneous cancers who completed the PRP were mailed the Hospital Anxiety and Depression Scale (among others) 3-month post-PRP (n = 44). Demographic and medical information were obtained from patient files.

Results

There was a significant linear trend (mean T1: 6.79 ± 2.29; T2: 5.23 ± 3.06; T3: 4.59 ± 3.34; p = 0.007) with statistically and clinically significant decreases in reported depressive symptomatology between T1 and T2 (p = 0.042) and T1 and T3 (p = 0.007). There was a significant decreases in number of cases reporting symptomatology scores in the clinical range from T1 to T3 (p = 0.038).

Conclusion

Patients who undergo a palliative rehabilitation program may experience relief of mild depressive symptomatology, maintainable 3-month post-PRP. The sample was exhibiting mild symptomatology and these results may not be generalizable to those with higher scores; a lack of specialized psychosocial clinician may have affected the acquired sample. Experimental designs are needed to more thoroughly compare these findings to independent rehabilitation interventions.

vorige artikel Prospective associations of exercise and depressive symptoms in older adults: the role of apolipoprotein E4

volgende artikel Comparing effects between music intervention and aromatherapy on anxiety of patients undergoing mechanical ventilation in the intensive care unit: a randomized controlled trial

Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., et al. (2011). FOLFIRINOX versus Gemcitabine for metastatic pancreatic cancer. New England Journal of Medicine. doi:10.1056/NEJMoa1011923.PubMed

Tangen, C., Faulkner, J., Crawford, E. D., Thompson, I., Hirano, D., Eisenberger, M., & Hussain, M. (2003). Ten-year survival in patients with metastatic prostate cancer. Clinical Genitourinary Cancer, 2, 41–45.

Esper, P. (2010). Symptom clusters in individuals living with advanced cancer. Seminars in Oncology Nursing. doi:10.1016/j.soncn.2010.05.002.PubMed

Haylock, P. J. (2010). Advanced cancer: Emergence of a new survivor population. Seminars in Oncology Nursing. doi:10.1016/j.soncn.2010.05.008.

Mayer, M. (2010). Lessons learned from the metastatic breast cancer community. Seminars in Oncology Nursing. doi:10.1016/j.soncn.2010.05.004.PubMed

Park, E. M., & Rosenstein, D. L. (2014). Living with advanced cancer: Unmet survivorship needs. North Carolina Medical Journal, 75, 279–282.CrossRefPubMed

Bruera, E., & Yennurajalingam, S. (2012). Palliative care in advanced cancer patients: How and when? The Oncologist. doi:10.1634/theoncologist.2011-0219.

Wilson, K.G., Lander, M., Chochinov, H.M. (2009). Diagnosis and management of depression in palliative care. In H.M. Chochinov, & W. Breitbart (Eds.). Psychiatry in palliative care (2nd edn, pp. 39–69). New York, NY: Oxford University Press.

Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011). Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. Lancet Oncology. doi:10.1016/S1470-2045(11)70002-X.

10.

Rodin, G. (2013). Research on psychological and social factors in palliative care: An invited commentary. Palliative Medicine. doi:10.1177/0269216313499961.

11.

Fils, J. M., Penick, E. C., Nickel, E. J., Othmer, E., DeSouza, C., Gabrielli, W. F., & Hunter, E. E. (2010). Minor versus major depression: A comparative clinical study. Primary Care Companion to Journal of Clinical Psychiatry. doi:10.4088/PCC.08m00752blu.

12.

Delgado-Guay, M., Parsons, H. A., Li, Z., Palmer, J. L., & Bruera, E. (2009). Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Supportive Care in Cancer. doi:10.1007/s00520-008-0529-7.

13.

Pinquart, M., & Duberstein, P. R. (2010). Depression and cancer mortality: A meta-analysis. Psychological Medicine. doi:10.1017/S0033291709992285.PubMedPubMedCentral

14.

Satin, J. R., Linden, W., & Phillips, M. J. (2010). Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis. Cancer. doi:10.1002/cncr.24561.

15.

Meeks, T. W., Vahia, I. V., Lavretsky, H., Kulkarni, G., & Jeste, D. V. (2011). A tune in “a minor” can “b major”: A review of epidemiology, illness course, and public health implications of subthreshold depression in older adults. Journal of Affective Disorders. doi:10.1016/j.jad.2010.09.015.PubMedPubMedCentral

16.

Currier, M. B., & Nemeroff, C. B. (2014). Depression as a risk factor for Cancer: From pathophysiological advances to treatment implications. Annual Review of Medicine. doi:10.1146/annurev-med-061212-171507.PubMed

17.

Li, M., & Rodin, G. (2010). Depression and illness. In J. M. Suis, K. W. Davidson & R. M. Kaplan (Eds.), Handbook of health psychology and behavioral medicine (pp. 217–233). New York: Guilford.

18.

Chasen, M., Feldstain, A., Gravelle, D., MacDonald, N., & Pereira, J. (2013). An interprofessional palliative care oncology rehabilitation program: Effects on function and predictors of program completion. Current Oncology. doi:10.3747/co.20.1607.

19.

Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84, 191–215.CrossRefPubMed

20.

Bandura, A. (2009). Self-efficacy. In I. B. Weiner & W. E. Craighead (Eds.), The Corsini Encyclopedia of Psychology (p. 1534). New York, NY: John Wiley & Sons, Inc.

21.

Luszczynska, A., Gutiérrez-Dona, B., & Schwarzer, R. (2005). General self-efficacy in various domains of human functioning: Evidence from five countries. International Journal of Psychology. doi:10.1080/00207590444000041.

22.

Feldstain, A., Lebel, S., & Chasen, M. R. (2016). An interdisciplinary palliative rehabilitation intervention bolstering general self-efficacy to attenuate symptoms of depression in patients living with advanced cancer. Supportive Care in Cancer. doi:10.1007/s00520-015-2751-4.PubMed

23.

Lynn, J., & Adamson, D.M. (2003). Living well at the end of life. Adapting health care to serious chronic illness in old age. Retrieved 15 July, 2014, from http://www.rand.org/pubs/white_papers/WP137.

24.

Krogh, J., Nordentoft, M., Sterne, J.A.C., & Lawlor, D. A. (2011). The effect of exercise in clinically depressed adults: Systematic review and meta-analysis of randomized controlled trials. Journal of Clinical Psychiatry. doi:10.4088/JCP.08r04913blu.PubMed

25.

Mead, G. E., Morley, W., Campbell, P., Greig, C. A., McMurdo, M., & Lawlor, D. A. (2009). Exercise for depression. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD004366.pub4.

26.

Mishra, S. I., Scherer, R. W., Geigle, P. M., Berlanstein, D. R., Topaloglu, O., Gotay, C. C., & Snyder, C. (2010). Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD007566.pub2.

27.

Rimer, J., Dwan, K., Lawlor, D. A., Greig, C. A., McMurdo, M., Morley, W., & Mead, G. E. (2012). Exercise for depression. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD004366.pub5.PubMed

28.

Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982). Toxicity and response criteria of the Eastern cooperative oncology group. American Journal of Clinical Oncology, 5, 649–655.CrossRefPubMed

29.

Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361–370.CrossRefPubMed

30.

Mitchell, A. J., Meader, N., & Symonds, P. (2010). Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: A meta-analysis. Journal of Affective Disorders. doi:10.1016/j.jad.2010.01.067.PubMedCentral

31.

Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the Hospital Anxiety and Depression Scale: An updated literature review. Journal of Psychosomatic Research, 52, 69–77.CrossRefPubMed

32.

Luckett, T., Butow, P., King, M., Oguchi, M., Heading, G., Hackl, N., et al. (2010). A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Supportive Care in Cancer. doi:10.1007/s00520-010-0932-8.PubMed

33.

Vodermaier, A., & Millman, R. D. (2011). Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: A systematic review and meta-analysis. Supportive Care in Cancer. doi:10.1007/s00520-011-1251-4.

34.

Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavioral Research Methods (San Diego, Calif.). doi:10.3758/BF03193146.

35.

Graham, J. W. (2012). Missing data analysis and design. New York: Springer.CrossRef

36.

Sinharay, S., Stern, H. S., & Russell, D. (2001). The use of multiple imputation for the analysis of missing data. Psychological Methods. doi:10.1037/1082-989X.6.4.317.PubMed

37.

Linden, A. (2013). Assessing regression to the mean effects in health care initiatives. BMC Medical Research Methodology. doi:10.1186/1471-2288-13-119.

38.

Rocconi, L. M., & Ethington, C. A. (2009). Assessing longitudinal change: Adjustment for regression to the mean effects. Research in Higher Education. doi:10.1007/s11162-009-9119-x.

39.

Sorensen, J. B., Klee, M., Palshof, T., & Hansen, H. H. (1993). Performance status assessment in cancer patients. An inter-observer variability study. British Journal of Cancer. doi:10.1038/bjc.1993.140.PubMedPubMedCentral

40.

Puhan, M. A., Frey, M., Büchi, S., & Schünemann, H. J. (2008). The minimal important difference of the hospital anxiety and depressive scale in patients with chronic obstructive pulmonary disease. Health and Quality of Life Outcomes. doi:10.1186/1477-7525-6-46.

41.

Cancer Journey Portfolio. (2012). Screening for Distress, the 6th Vital Sign: A Guide to Implementing Best Practices in Person-Centred Care. Retrieved 22 Dec, 2016 http://www.cancerview.ca.

42.

Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008). Major depression after breast cancer: A review of epidemiology and treatment. General Hospital Psychiatry. doi:10.1016/j.genhosppsych.2007.10.008.PubMed

43.

Rodriguez, A. M., Mayo, N. E., & Gagnon, B. (2013). Independent contributors to overall quality of life in people with advanced cancer. British Journal of Cancer. doi:10.1038/bjc.2013.146.

44.

Jaremka, L. M., Fagundes, C. P., Glaser, R., Bennett, J. M., Malarkey, W. B., & Kiecolt-Glaser, J. K. (2013). Loneliness predicts pain, depression, and fatigue: Understanding the role of immune dysregulation. Psychoneuroendocrinology. doi:10.1016/j.psyneuen.2012.PubMedCentral

Titel: The longitudinal course of depression symptomatology following a palliative rehabilitation program
Auteurs: Andrea Feldstain
Sophie Lebel
Martin R. Chasen
Publicatiedatum: 24-02-2017
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 7/2017
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-017-1531-7

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 7/2017

Gender-related differences in the multi-pathway effect of social determinants on quality of life in older age—the COURAGE in Europe project

Understanding burden of illness for child growth hormone deficiency

The Weiss Functional Impairment Rating Scale-Parent Form for assessing ADHD: evaluating diagnostic accuracy and determining optimal thresholds using ROC analysis

General health status in army personnel: relations with health behaviors and psychosocial variables

Comparison of quality of life among long-term melanoma survivors and non-melanoma controls: a cross-sectional study

Systematic review of the health-related quality of life issues facing adolescents and young adults with cancer